HR1143-119

Introduced

To amend title XVIII of the Social Security Act to expand coverage of the in-home administration of intravenous immune globulin under the Medicare program.

119th Congress Introduced Feb 7, 2025

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

The bill expands a appropriation, delegation of rulemaking provision: 2. Expanding coverage of the in-home administration of intravenous immune globulin under the Medicare program Section 1861 of the Social Security Act (42. It relies on appropriations and delegation of rulemaking. The main policy areas are Healthcare.

Who Benefits and How

The available clause analysis does not identify a specific beneficiary group.

Who Bears the Burden and How

No clear private burden is identified from the available clause analysis; implementing agencies may still take on administrative work.

Key Provisions

  • Expands a appropriation, delegation of rulemaking provision: 2. Expanding coverage of the in-home administration of intravenous immune globulin under the Medicare program Section 1861 of the Social Security Act (42...

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for primary purpose and policy domains.

At a Glance

What This Bill Does

The bill expands a appropriation, delegation of rulemaking provision: 2. Expanding coverage of the in-home administration of intravenous immune globulin under the Medicare program Section 1861 of the Social Security Act (42.

Key Policy Areas

Healthcare

Primary Purpose

The bill expands a appropriation, delegation of rulemaking provision: 2. Expanding coverage of the in-home administration of intravenous immune globulin under the Medicare program Section 1861 of the Social Security Act (42.

Policy Domains

Healthcare

Legislative Progress

Introduced
Introduced Committee Passed
Feb 7, 2025

Mr. Smith of Nebraska (for himself and Mr. Garamendi) introduced …

Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare
Actor Mappings
"the_secretary"
→ The Secretary identified in the operative section

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology